Subject category:
Production and Operations Management
Published by:
Harvard Business Publishing
Version: 23 June 2000
Abstract
Describes the creation and operation of the initial two heavyweight teams for new drug development and launch. The primary focus is on one of those two teams, Evista, although comparisons to the other team, Zyprexa, are included. Lilly must decide the next phase (post launch) for managing Evista''s rollout.; Operational realities of heavyweight development teams and their transition following product launch.
About
Abstract
Describes the creation and operation of the initial two heavyweight teams for new drug development and launch. The primary focus is on one of those two teams, Evista, although comparisons to the other team, Zyprexa, are included. Lilly must decide the next phase (post launch) for managing Evista''s rollout.; Operational realities of heavyweight development teams and their transition following product launch.